Katrin Sak

7.6k total citations · 4 hit papers
125 papers, 5.9k citations indexed

About

Katrin Sak is a scholar working on Molecular Biology, Pharmacology and Physiology. According to data from OpenAlex, Katrin Sak has authored 125 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Molecular Biology, 17 papers in Pharmacology and 17 papers in Physiology. Recurrent topics in Katrin Sak's work include Adenosine and Purinergic Signaling (17 papers), Phytochemicals and Antioxidant Activities (15 papers) and Flavonoids in Medical Research (12 papers). Katrin Sak is often cited by papers focused on Adenosine and Purinergic Signaling (17 papers), Phytochemicals and Antioxidant Activities (15 papers) and Flavonoids in Medical Research (12 papers). Katrin Sak collaborates with scholars based in India, Estonia and Türkiye. Katrin Sak's co-authors include Hardeep Singh Tuli, Vaishali Aggarwal, Dharambir Kashyap, Gautam Sethi, Mükerrem Betül Yerer, Aklank Jain, Ajay Sharma, Mehmet Varol, Falak Thakral and Anupam Bishayee and has published in prestigious journals such as SHILAP Revista de lepidopterología, Trends in Biochemical Sciences and Biochemical and Biophysical Research Communications.

In The Last Decade

Katrin Sak

119 papers receiving 5.8k citations

Hit Papers

Role of Reactive Oxygen Species in Cancer Progress... 2014 2026 2018 2022 2019 2014 2019 2019 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katrin Sak India 37 2.8k 734 729 705 608 125 5.9k
Jung Han Yoon Park South Korea 49 3.4k 1.2× 655 0.9× 892 1.2× 538 0.8× 775 1.3× 185 6.5k
Miguel López‐Lázaro Spain 34 2.8k 1.0× 733 1.0× 857 1.2× 525 0.7× 668 1.1× 98 5.8k
Hardeep Singh Tuli India 43 3.3k 1.2× 750 1.0× 897 1.2× 1.1k 1.6× 733 1.2× 253 7.3k
Joydeb Kumar Kundu South Korea 43 3.0k 1.1× 729 1.0× 603 0.8× 546 0.8× 527 0.9× 83 5.8k
Kyung‐Soo Chun South Korea 37 2.9k 1.0× 604 0.8× 596 0.8× 960 1.4× 669 1.1× 101 5.8k
Yi Chen China 37 2.3k 0.8× 695 0.9× 729 1.0× 620 0.9× 508 0.8× 151 5.5k
Hye‐Kyung Na South Korea 43 3.4k 1.2× 685 0.9× 485 0.7× 699 1.0× 637 1.0× 106 5.9k
Jae‐Young Um South Korea 45 3.5k 1.3× 495 0.7× 824 1.1× 759 1.1× 845 1.4× 263 7.5k
Nam Deuk Kim South Korea 43 2.9k 1.1× 480 0.7× 735 1.0× 820 1.2× 779 1.3× 162 6.2k
Mahadev Rao India 40 3.3k 1.2× 879 1.2× 896 1.2× 541 0.8× 710 1.2× 160 7.8k

Countries citing papers authored by Katrin Sak

Since Specialization
Citations

This map shows the geographic impact of Katrin Sak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katrin Sak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katrin Sak more than expected).

Fields of papers citing papers by Katrin Sak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katrin Sak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katrin Sak. The network helps show where Katrin Sak may publish in the future.

Co-authorship network of co-authors of Katrin Sak

This figure shows the co-authorship network connecting the top 25 collaborators of Katrin Sak. A scholar is included among the top collaborators of Katrin Sak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katrin Sak. Katrin Sak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sak, Katrin. (2024). The path of GPR87: from a P2Y-like receptor to its role in cancer progression. Naunyn-Schmiedeberg s Archives of Pharmacology. 398(5). 4803–4815.
2.
Tuli, Hardeep Singh, Reena V. Saini, Adesh K. Saini, et al.. (2024). Flavonoid-Mediated Suppression of Tumor Angiogenesis: Roles of Ang-Tie/PI3K/AKT. Pathophysiology. 31(4). 596–607. 5 indexed citations
3.
Sak, Katrin. (2024). High intake of sunflower seeds and low mortality from Alzheimer’s disease and dementia: is there a correlation?. SHILAP Revista de lepidopterología. 2(2). 101–106. 3 indexed citations
4.
Tuli, Hardeep Singh, Ajay Kumar, Poonam Aggarwal, et al.. (2023). Autophagy Induction by Scutellaria Flavones in Cancer: Recent Advances. Pharmaceuticals. 16(2). 302–302. 10 indexed citations
5.
Hussain, Arif, Ajay Kumar, Uttam Sharma, et al.. (2023). Application of curcumin nanoformulations to target folic acid receptor in cancer: Recent trends and advances. Environmental Research. 233. 116476–116476. 25 indexed citations
6.
Sethi, Gautam, Prangya Rath, Abhishek Chauhan, et al.. (2023). Apoptotic Mechanisms of Quercetin in Liver Cancer: Recent Trends and Advancements. Pharmaceutics. 15(2). 712–712. 69 indexed citations
8.
Tuli, Hardeep Singh, Vivek Kumar Garg, Ginpreet Kaur, et al.. (2022). Licorice (Glycyrrhiza glabra L.)-Derived Phytochemicals Target Multiple Signaling Pathways to Confer Oncopreventive and Oncotherapeutic Effects. OncoTargets and Therapy. Volume 15. 1419–1448. 17 indexed citations
9.
Tuli, Hardeep Singh, Ajay Kumar, Katrin Sak, et al.. (2022). Gut Microbiota-Assisted Synthesis, Cellular Interactions and Synergistic Perspectives of Equol as a Potent Anticancer Isoflavone. Pharmaceuticals. 15(11). 1418–1418. 11 indexed citations
10.
Tuli, Hardeep Singh, Prangya Rath, Abhishek Chauhan, et al.. (2022). Phloretin, as a Potent Anticancer Compound: From Chemistry to Cellular Interactions. Molecules. 27(24). 8819–8819. 35 indexed citations
11.
Tuli, Hardeep Singh, Ajay Kumar, Seema Ramniwas, et al.. (2022). Ferulic Acid: A Natural Phenol That Inhibits Neoplastic Events through Modulation of Oncogenic Signaling. Molecules. 27(21). 7653–7653. 41 indexed citations
12.
Tuli, Hardeep Singh, Prangya Rath, Abhishek Chauhan, et al.. (2022). Luteolin, a Potent Anticancer Compound: From Chemistry to Cellular Interactions and Synergetic Perspectives. Cancers. 14(21). 5373–5373. 54 indexed citations
13.
Tuli, Hardeep Singh, Vivek Kumar Garg, Uttam Sharma, et al.. (2022). Natural flavonoids exhibit potent anticancer activity by targeting microRNAs in cancer: A signature step hinting towards clinical perfection. Translational Oncology. 27. 101596–101596. 51 indexed citations
14.
Tuli, Hardeep Singh, Sonam Mittal, Vaishali Aggarwal, et al.. (2021). Deguelin targets multiple oncogenic signaling pathways to combat human malignancies. Pharmacological Research. 166. 105487–105487. 26 indexed citations
15.
Aggarwal, Vaishali, Hardeep Singh Tuli, Mehmet Varol, et al.. (2021). NOTCH signaling: Journey of an evolutionarily conserved pathway in driving tumor progression and its modulation as a therapeutic target. Critical Reviews in Oncology/Hematology. 164. 103403–103403. 21 indexed citations
16.
Tuli, Hardeep Singh, Sonam Mittal, Diwakar Aggarwal, et al.. (2020). Path of Silibinin from diet to medicine: A dietary polyphenolic flavonoid having potential anti-cancer therapeutic significance. Seminars in Cancer Biology. 73. 196–218. 78 indexed citations
17.
Aggarwal, Vaishali, Hardeep Singh Tuli, Ayşegül Varol, et al.. (2019). Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements. Biomolecules. 9(11). 735–735. 859 indexed citations breakdown →
19.
Sak, Katrin. (2017). A supposed mechanism of synergistic action of catechol-containing natural polyphenols. International Journal of Phytomedicine. 9(2). 207–212. 1 indexed citations
20.
Sak, Katrin. (2014). Anticancer effects of flavonoids on melanoma cells: are murine cells more sensitive compared to humans?. International Journal of Phytomedicine. 5(4). 441–445. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026